首页> 外国专利> CONSTRUCTION OF DNA EXPRESSION FOR THE TREATMENT OF INFECTIONS BY LEISHMANIOSIS.

CONSTRUCTION OF DNA EXPRESSION FOR THE TREATMENT OF INFECTIONS BY LEISHMANIOSIS.

机译:利什曼病治疗感染DNA的构建。

摘要

DNA expression construct for immunization against leishmaniosis infections, characterized in that the polynucleotide sequences that confer immunization are expression constructs consisting of linear covalent closed deoxyribonucleic acid molecules that have a linear double stranded zone, where the individual strands that they form the double stranded pairing are linked by short single stranded loops of deoxyribonucleic acid nucleotides, wherein said strands consist only of the coding sequence that encodes at least the p36 LACK antigen under the control of a promoter that is put into operation in the animal to which it is to be vaccinated and of a terminator sequence, and wherein the DNA expression construct is covalently linked with one or more oligopeptides to increase the efficiency of transfection and the oligopeptide consists of a number of amino acids ranging from 3 to 30, of which at less than half are basic amino acids of the group formed by arginine or lysine.
机译:用于针对利什曼病感染进行免疫接种的DNA表达构建体,其特征在于,赋予免疫作用的多核苷酸序列是由具有线性双链区的线性共价封闭式脱氧核糖核酸分子组成的表达构建体,其中形成双链对的各个链被连接通过脱氧核糖核酸核苷酸的短单链环,其中所述链仅由编码序列组成,所述编码序列至少在要对其进行疫苗接种的动物中操作的启动子的控制下编码p36 LACK抗原。终止序列,并且其中DNA表达构建体与一个或多个寡肽共价连接以增加转染效率,并且寡肽由3至30个范围内的许多氨基酸组成,其中少于一半是碱性氨基酸由精氨酸或赖氨酸形成的基团。

著录项

  • 公开/公告号ES2242888T3

    专利类型

  • 公开/公告日2005-11-16

    原文格式PDF

  • 申请/专利权人 MOLOGEN AG;

    申请/专利号ES20020781133T

  • 发明设计人 LOPEZ FUERTES LAURA;TIMON JIMENEZ MARCOS;

    申请日2002-10-02

  • 分类号C12N15/30;

  • 国家 ES

  • 入库时间 2022-08-21 21:36:05

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号